Therapixel - About the company
Therapixel is a series B company based in Nice (France), founded in 2013 by Olivier Clatz. It operates as a Provider of medical image analytics platform for surgeons. Therapixel has raised $22.1M in funding from investors like Omnes Capital, Turenne Groupe and Inria. The company has 566 active competitors, including 114 funded and 31 that have exited. Its top competitors include companies like HeartFlow, Oxipit and ScreenPoint.
Company Details
Therapixel offers an analytics platform for visualization and analysis of medical images in the operating theaters. The image navigation system uses machine learning algorithms to optimize breast cancer detection in patients. The AI system work through a motion sensor positioned on top of the screen, which transforms hand gestures into control commands for the system. The technology offered by the company is based on research at INRIA.
- Website
- www.therapixel.com/
- Email ID
- *****@therapixel.com
- Phone Number
- +33 **********
Key Metrics
Founded Year
2013
Location
Nice, France
Stage
Series B
Total Funding
$22.1M in 4 rounds
Latest Funding Round
Investors
Ranked
22nd among 566 active competitors
Employee Count
61 as on Jul 31, 2026
Similar Companies
Legal entities associated with Therapixel
Therapixel is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
THERAPIXEL CIN: 793920521 , France, Deadpooled | May 19, 2020 | - | - | - |
Sign up to download Therapixel's company profile
Therapixel's funding and investors
Therapixel has raised a total funding of $22.1M over 4 rounds. Its first funding round was on Nov 12, 2015. Its latest funding round was a Series B round on May 12, 2022 for $*****. 8 investors participated in its latest round. Therapixel has 19 institutional investors.
Here is the list of recent funding rounds of Therapixel:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 12, 2022 | 1386076 | Series B | 2950832 | 8978789 | 1486306 | 1017968 |
Mar 13, 2019 | 8542090 | Series A | 3404584 | 9504698 | 8225383 | |
2017 | 4602 | Grant (prize money) | 5997 | 3671 | 2331 | 7287 |
View details of Therapixel's funding rounds and investors
Therapixel's founders and board of directors
Founder? Claim ProfileThe founders of Therapixel is Olivier Clatz. Matthieu Leclerc Chalvet is the CEO of Therapixel.
Here are the details of Therapixel's key team members:
- Olivier Clatz: Former Co-Founder of Therapixel.
- Matthieu Leclerc Chalvet: Co-CEO of Therapixel.
View details of Therapixel's Founder profiles and Board Members
Therapixel's employee count trend
Therapixel has 61 employees as of Jul 26. Here is Therapixel's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Therapixel's Competitors and alternates
Top competitors of Therapixel include HeartFlow, Oxipit and ScreenPoint. Here is the list of Top 10 competitors of Therapixel, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | HeartFlow 2007, Redwood City (United States), Public | Provides cardiovascular diagnostic support using analytics | $936M | 70/100 | |
2nd | Developer of medical imaging software for automated radiology diagnostic support | $6.69M | 66/100 | ||
3rd | ScreenPoint 2014, Nijmegen (Netherlands), Series C | Developer of artificial intelligence software for analyzing breast imaging mammograms | $47M | 64/100 | |
4th | Vista 2012, Palo Alto (United States), Series B | AI-guided software for clinicians to automate MRI exams | $38.2M | 62/100 | |
5th | Provider of AI-based breast cancer screening software for clinics | $20.3M | 61/100 | ||
6th | AI-powered tool for the detection of heart risk | $19.1M | 61/100 | ||
7th | Olea Medical 2008, La Ciotat (France), Acquired | Developer of medical diagnostic software solutions for image post-processing | $6.7M | 61/100 | |
8th | Optellum 2015, Oxford (United Kingdom), Series A | Provider of AI-based cancer diagnostics platform | $20.6M | 61/100 | |
9th | DeepHealth 2015, Cambridge (United States), Funding Raised | AI-powered mammography interpretation software | - | 58/100 | |
10th | Skin Analytics 2012, London (United Kingdom), Series B | Provider of smartphone based skin cancer detection | $32.6M | 58/100 | |
22nd | Therapixel 2013, Nice (France), Series B | Provider of medical image analytics platform for surgeons | $22.1M | 51/100 |
Looking for more details on Therapixel's competitors? Click here to see the top ones
Therapixel's Investments and acquisitions
Therapixel has made no investments or acquisitions yet.
Reports related to Therapixel
Here is the latest report on Therapixel's sector:
News related to Therapixel
•
RamSoft and Therapixel Partner to Deliver AI-Powered Breast Imaging SolutionPR Newswire•May 21, 2025•RamSoft, Therapixel
•
•
•
Therapixel Closes €15M Series B FinancingFinSMEs•May 16, 2022•Therapixel, Credit Mutuel Equity, Caphorn, Verve Ventures and 6 others
•
Therapixel announces close of 15 M series B financing to deploy MammoScreen 2D/3Duserwalls.com•May 12, 2022•Therapixel, Credit Mutuel Equity, Caphorn, Verve Ventures and 10 others
•
•
•
•
Therapixel Earns FDA 510(k) Clearance for MammoScreen AI SoftwareAPPLIED RADIOLOGY•Jul 09, 2020•Therapixel
•
Are you a Founder ?
FAQs about Therapixel
Explore our recently published companies
- Solar - Indore based, 1994 founded, Unfunded company
- Bina Punjani - India based, 2011 founded, Unfunded company
- Aviator - India based, Unfunded company
- Admit Beacon - India based, 2021 founded, Unfunded company
- Origin Itfs - Chennai based, 1993 founded, Unfunded company
- 1Win - India based, 2026 founded, Unfunded company
